Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Shiyi Yang | Researchclopedia

Back to researchers

Shiyi Yang

Southwest Petroleum University ORCID

38

Works

1,692

Citations

11

h-index

14

i10-index

Research Topics

Multiple Myeloma Research and Treatments Gene expression and cancer classification Monoclonal and Polyclonal Antibodies Research

Affiliations

Boston University2019–2022

Nanjing Normal University2022–2022

Southwest Petroleum University2025–2025

Yunnan University2017–2017

Anhui Medical University2020–2020

Top Works

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma

Ajai Chari,Monique C. Minnema,et al.

2022599 citations

Chronic Lymphocytic Leukemia Research

Single-cell and spatial transcriptomics

Decontamination of ambient RNA in single-cell RNA-seq with DecontX

Shiyi Yang,Sean Corbett,et al.

2020589 citations

Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open‐label studies

Simon Rule,Martin Dreyling,et al.

2017141 citations

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study

Ajai Chari,Paula Rodríguez‐Otero,et al.

202061 citations

Decontamination of ambient RNA in single-cell RNA-seq with DecontX

Shiyi Yang,Sean Corbett,et al.

201953 citations

Updated Phase 1 Results from MonumenTAL-1: First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Amrita Krishnan,Monique C. Minnema,et al.

202151 citations

Celda: a Bayesian model to perform co-clustering of genes into modules and cells into subpopulations using single-cell RNA-seq data

Zhe Wang,Shiyi Yang,et al.

202240 citations

Efficacy and safety of talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Updated results from MonumenTAL-1.

Monique C. Minnema,Amrita Krishnan,et al.

202227 citations

Daratumumab (DARA) with Bortezomib, Thalidomide, and Dexamethasone (VTd) in Transplant-Eligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) Negativity in Cassiopeia Part 1 and Part 2

Hervé Avet‐Loiseau,Pieter Sonneveld,et al.

202120 citations